JPH0434968B2 - - Google Patents
Info
- Publication number
- JPH0434968B2 JPH0434968B2 JP59228973A JP22897384A JPH0434968B2 JP H0434968 B2 JPH0434968 B2 JP H0434968B2 JP 59228973 A JP59228973 A JP 59228973A JP 22897384 A JP22897384 A JP 22897384A JP H0434968 B2 JPH0434968 B2 JP H0434968B2
- Authority
- JP
- Japan
- Prior art keywords
- maltol
- growth
- bacteria
- present
- caries
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 claims description 34
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 claims description 16
- 229940043353 maltol Drugs 0.000 claims description 16
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 claims description 15
- 229940093503 ethyl maltol Drugs 0.000 claims description 14
- 208000002925 dental caries Diseases 0.000 claims description 10
- 239000003966 growth inhibitor Substances 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 description 12
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 230000001013 cariogenic effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 241000194019 Streptococcus mutans Species 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920001503 Glucan Polymers 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- OXXDGKNPRNPMLS-UHFFFAOYSA-N 2-Hydroxy-3-methyl-4H-pyran-4-one Natural products CC1=C(O)OC=CC1=O OXXDGKNPRNPMLS-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
(産業上の利用分野)
本発明はう蝕(虫歯)の形成に大きく関与して
いるストレプトコツカス・ミユータンス
(Streptococcus mutans)に代表される口腔内細
菌に対して優れた抗菌活性を示す、う蝕菌生育阻
害剤に関する。
(従来の技術)
従来、口腔内細菌の生育を阻害する薬剤として
はクロルヘキシジン、抗生物質等の使用が知られ
ている外、多くの合成品、天然品が報告されてい
る。
(発明が解決しようとする問題点)
しかしながら、これら公知の口腔内細菌の生育
阻害剤は投与方法、投与量によつては人体に対す
る安全性に問題があつたり、安定性が確認されて
いるものは抗菌性が低かつたり、また投与した
際、不快な臭がするなどの欠点があつた。
本発明の目的は人体に対する安全性が確認され
ており、且つ抗菌性が高く、しかも快い芳香を有
するう蝕菌生育阻害剤を提供することにある。
(問題点を解決するための手段)
本発明によれば、マルトール及び/またはエチ
ルマルトールを有効成分として含有することを特
徴とするう蝕菌生育阻害剤が提供される。
以下本発明につき更に詳細に説明する。
一般にう蝕(虫歯)形成の原因としては歯質
(Teeth)と基質(Substrate)とミユータンス菌
(St.mutans)とを挙げることができ、この3つ
の要因が同時に存在するとき、う蝕(虫歯)が発
生するとされている。う蝕(虫歯)形成のメカニ
ズムは、例えば糖類の中で砂糖を基質
(Substrate)とした場合、この砂糖がミユータン
ス菌(St.mutans)の産出するグルコキシトラン
スフエラーゼ(酵素)によつ水に不溶性で粘着性
のデキストラン(グルカン)に変化し、歯質
(Teeth)の表面に歯垢を形成する。この歯垢の
中では嫌気状態となり乳酸菌等により醗酵が進み
乳酸が生成してPHが低下し、この乳酸が歯のエ
ナメル質を脱灰しう蝕(虫歯)を形成するとされ
ている。
従つて、ストレプトコツカス・ミユータンス
(St.mutans)に代表される口腔内細菌の増殖を
抑え歯垢の形成を阻止することはう蝕(虫歯)の
形成を予防する有効な方法である。本発明者等は
既に人体に安全性が確認され且う蝕(虫歯)形成
に大きく関与しているストレプトコツカス・ミユ
ータンス菌(St.mutans)の生育を阻害する条件
に適合する物質を鋭意探索研究した結果、マルト
ール及び/またはエチルマルトールが非常に有効
であることを見出し、本発明を完成するに至つ
た。
本発明にて用いるマルトール及びエチルマルト
ールはすでに公知物質であり、下記に差の化学構
造式及び化学名を示す。
3−ハイドロキシ−2−メチル−4−ピロン
(マルトール)
3−ハイドロキシ−2−エチル−4−ピロン
(エチルマルトール)
本発明にて用いるマルトールは市販品、例えば
ピロマトール(大塚化学(株)、商品名)及びベルト
ール(フアイザー(株)、商品名)またエチルマルト
ールは市販品、例えばピロマトールE(大塚化学
(株)、商品名)及びベルトールプラス(フアイザー
(株)、市販品)を使用することができる。
本発明にて用いるマルトール及びエチルマルト
ールはGRASリスト(No.2656,No.3487)及び
FDAリスト(〓121・1164,〓121・1164)に
各々記載の既に安全性の確認された香料物質であ
り、香味剤または香味改良増強剤(Flavor
enhancer)として、例えばチヨコレート製品、
パン類、砂糖菓子、アルコール飲料、肉製品、酪
農製品、アイスクリーム、缶詰食品、タバコ、歯
磨、口紅、保健製品、動物飼料等に広く利用され
ている。〔香料化学総覧()、奥田治著、940頁、
広川書店発行〕。
この様な口腔内で快い芳香を漂わせる香料物質
がう蝕菌生育阻害剤として優れた効果を示すこと
は驚くべき事である。
本発明のマルトールとエチルマルトールとは併
用してもよく、また一方のみを単独で用いてもよ
い。
本発明のう蝕菌生育阻害剤の投与形態としては
口腔中で比較的滞留時間の長い錠果、チユーイン
ガム、キヤンデー、トローチ等に配合させること
によりその効果が期待できる外、本発明のう蝕菌
生育阻害剤は界面活性剤による抗菌活性も殆ど無
いので歯磨、マウスウオシユ等の口腔清浄剤にも
配合しても使用できる。その配合量は対象製品の
形態、種類等によつて必ずしも一様ではないが口
腔用組成物0.005%/10重量%、好ましくは0.01
〜5重量%配合するのが一般的である。
本発明のう蝕菌生育阻害剤を配合した処方例を
下記に示す。
処方例 1
常法に従い、以下に示す組成物のチユーインガ
ムを製造した。
成 分 重量%
ガムベース 20
粉 糖 35
マルトース 10
フルクトース 10
水アメ 15
香 料 1
マルトール 0.4
水 残部
100%
処方例 2
常法に従い、以下に示す組成物のマウスウオツ
シユを製造した。
成 分 重量%
エタノール 20
サツカリン 0.5
グリセリン 50
シヨ糖ラウリレート 2
ツロルヘキシジン 0.5
香 料 1
エチルマルトール 0.5
水 残部
100%
処方例 3
常法に従い、以下に示す組成物のトローチを製
造した。
成 分 重量%
アラビアガム 8
マルトース 30
フルクトース 20
グルコース 20
香 料 0.2
マルトール 0.2
水 残部
100%
(実施例)
次に本発明のマルトール及びエチルマルトール
の抗菌活性効果を実施例により本発明を更に詳細
に説明する。
実施例 1)
ペプトン1%、酵母エキス0.5%、シヨ糖2%、
PH7.0の寒天培地を調製し、滅菌冷却後、これに
24時間培養したストレプトコツカス・ミユータン
ス(Streptococcus mutans)RIMD−3125001株
の培養液0.5%を添加し、直ちに直径80mmの滅菌
シヤーレに12mlづつ文注した。次に直径8mmのペ
パーデイスクに試料化合物を含させ、上記のシヤ
ーレの寒天培地中央にのせ、37℃にて72時間倒置
培養した。
抗菌活性の試験(予備テスト)の判定は次の様
にして行つた。透明な寒天培地は菌が増殖すると
白濁してくるが試料の抗菌活性が有ればペパーデ
イスク周辺は透明が保持されるので、このクリア
ゾーン(以下阻止円直径という)を測定して、そ
の阻止円直径40mm以上を増殖阻止効果が有効であ
ると評価した。
(Field of Industrial Application) The present invention is a dental carcinogen that exhibits excellent antibacterial activity against oral bacteria represented by Streptococcus mutans, which is greatly involved in the formation of dental caries. Concerning a cariogenic fungus growth inhibitor. (Prior Art) Chlorhexidine, antibiotics, and the like have been known to be used as drugs that inhibit the growth of oral bacteria, and many synthetic and natural products have been reported. (Problems to be Solved by the Invention) However, these known oral bacteria growth inhibitors may have safety issues for the human body depending on the administration method and dosage, and their stability has not been confirmed. However, it has drawbacks such as low antibacterial properties and an unpleasant odor when administered. An object of the present invention is to provide a cariogenic bacteria growth inhibitor that has been confirmed to be safe for the human body, has high antibacterial properties, and has a pleasant aroma. (Means for Solving the Problems) According to the present invention, there is provided a cariogenic fungus growth inhibitor characterized by containing maltol and/or ethyl maltol as an active ingredient. The present invention will be explained in more detail below. In general, the causes of dental caries (cavities) formation include tooth substance, substrate, and St. mutans, and when these three factors exist at the same time, caries (caries) occurs. ) is said to occur. The mechanism of caries formation is, for example, when sugar is used as a substrate among sugars, this sugar is hydrated by glucoxytransferase (enzyme) produced by St. mutans. It changes into insoluble and sticky dextran (glucan) and forms plaque on the surface of teeth. This dental plaque becomes anaerobic and fermentation progresses due to lactic acid bacteria, etc., producing lactic acid and lowering the pH. This lactic acid is said to demineralize tooth enamel and form caries (cavities). Therefore, suppressing the growth of oral bacteria such as St. mutans and inhibiting the formation of dental plaque is an effective method for preventing the formation of dental caries. The present inventors are actively searching for a substance that is compatible with the conditions of inhibiting the growth of St. mutans, which has already been confirmed to be safe for the human body and is significantly involved in caries formation. As a result of research, it was discovered that maltol and/or ethyl maltol are very effective, leading to the completion of the present invention. Maltol and ethylmaltol used in the present invention are already known substances, and the different chemical structural formulas and chemical names are shown below. 3-Hydroxy-2-methyl-4-pyrone (maltol) 3-Hydroxy-2-ethyl-4-pyrone (ethyl maltol) The maltol used in the present invention is a commercially available product, such as pyromatol (Otsuka Chemical Co., Ltd., trade name) and bertol (Phizer Co., Ltd., trade name) and ethyl maltol. Maltol is a commercially available product, such as pyromatol E (Otsuka Chemical Co., Ltd.).
Co., Ltd., product name) and Bertol Plus (Phaseiser
Co., Ltd., commercially available products) can be used. Maltol and ethyl maltol used in the present invention are listed in the GRAS list (No. 2656, No. 3487) and
It is a flavoring substance whose safety has already been confirmed and is listed on the FDA list (〓121・1164,〓121・1164), and it is a flavoring agent or flavor improvement enhancer (Flavor
enhancer), such as Chiyocolate products,
It is widely used in breads, sugar confections, alcoholic beverages, meat products, dairy products, ice cream, canned foods, tobacco, toothpaste, lipstick, health products, animal feed, etc. [Overview of Fragrance Chemistry (), Osamu Okuda, 940 pages,
Published by Hirokawa Shoten]. It is surprising that a flavoring substance that gives off a pleasant aroma in the oral cavity exhibits excellent effects as a cariogenic bacteria growth inhibitor. The maltol and ethyl maltol of the present invention may be used together, or one of them may be used alone. The cariogenic bacteria growth inhibitor of the present invention can be expected to be effective when incorporated into tablets, chewing gum, candy, troches, etc., which have a relatively long residence time in the oral cavity. Since growth inhibitors have almost no antibacterial activity due to surfactants, they can also be used in combination with oral cleansers such as toothpastes and mouthwashes. The blending amount is not necessarily uniform depending on the form and type of the target product, but it is 0.005%/10% by weight of the oral composition, preferably 0.01%.
Generally, it is blended in an amount of ~5% by weight. Examples of formulations containing the caries growth inhibitor of the present invention are shown below. Formulation Example 1 Chewing gum of the composition shown below was manufactured according to a conventional method. Ingredient weight% Gum base 20 Powder sugar 35 Maltose 10 Fructose 10 Starch syrup 15 Flavor 1 Maltol 0.4 Water Balance 100% Formulation example 2 A mouthwash of the composition shown below was produced according to a conventional method. Ingredient weight % Ethanol 20 Saccharin 0.5 Glycerin 50 Sucrose laurylate 2 Turolhexidine 0.5 Flavor 1 Ethyl maltol 0.5 Water Balance 100% Formulation Example 3 A troche of the composition shown below was produced according to a conventional method. Ingredients Weight% Gum Arabic 8 Maltose 30 Fructose 20 Glucose 20 Flavor 0.2 Maltol 0.2 Water Balance 100% (Example) Next, the antibacterial activity of maltol and ethyl maltol of the present invention will be explained in more detail by Examples. do. Example 1) Peptone 1%, yeast extract 0.5%, sucrose 2%,
Prepare an agar medium with a pH of 7.0, sterilize it, cool it, and add it to it.
0.5% of the culture solution of Streptococcus mutans RIMD-3125001 strain cultured for 24 hours was added, and 12 ml of each was immediately poured into a sterilized jar with a diameter of 80 mm. Next, a pepper disc with a diameter of 8 mm was impregnated with the sample compound, placed on the center of the above-mentioned Schare's agar medium, and cultured upside down at 37°C for 72 hours. The antibacterial activity test (preliminary test) was evaluated as follows. A transparent agar medium becomes cloudy when bacteria proliferate, but if the sample has antibacterial activity, the area around the pepper disc will remain transparent, so this clear zone (hereinafter referred to as the inhibition circle diameter) will be measured to determine the inhibition. A circle diameter of 40 mm or more was evaluated as having an effective growth inhibition effect.
【表】
表−1の結果からマルトールは優れた菌の増殖
効果を示したが、殊にエチルマルトールは極めて
著しい阻止効果を示した。
実施例 2)
シヨ糖2%添加のハートインフユージヨン寒天
培地(pH7.0)を使用した以外は実施例1と同じ
ミユータンス菌を用い、同じ方法で実施した結
果、次の表−2で示される結果が得られた。[Table] From the results shown in Table 1, maltol showed an excellent bacterial growth effect, and ethyl maltol in particular showed a very remarkable inhibiting effect. Example 2) The same method was used as in Example 1, except that a heart infusion agar medium (pH 7.0) containing 2% sucrose was used, and the results were as shown in Table 2 below. The results obtained were as follows.
【表】
表−2の結果からマルトールは優れた増殖阻止
効果を示したが、殊にエチルマルトールは極めて
著しい阻止効果を示した。
実施例 3)
ストレプトコツカス・ミユータンス
(Streptococcus mutans)RIMD−3125002(E49)
株を使用する以外は実施例−1と同じ培地を用
い、同じ方法で実施した結果、次の表−3で示さ
れる結果が得られた。[Table] From the results shown in Table 2, maltol showed an excellent growth-inhibiting effect, and ethyl maltol in particular showed a very remarkable inhibiting effect. Example 3) Streptococcus mutans RIMD-3125002 (E49)
As a result of using the same medium and the same method as in Example 1 except for using the different strains, the results shown in Table 3 below were obtained.
【表】
表−3の結果からマルトール及びエチルマルト
ールとも極めて著しい菌増殖の阻止効果を示し
た。
実施例 4)
シヨ糖2%添加のハートインフユージヨンブイ
ヨンの液体培地(pH7.0)にマルトール0.02%
(1/5000濃度)添加し、これに前培養しておい
てストレプトコツカス・ミユータンス
(Streptococcus mutans)3125001株の培養液を
0.5%添加し、窒素デシケター中で37℃にて24時
間培養し、菌の生育状態をチエツクした結果、培
地のpHの低下もなく、またグルカンの形成も見
られなかつた事により、完全に菌の生育を阻止す
ることができた。また本試料の実用化を目的にソ
ジウムラウリルサルフエート0.5%の共存下にお
ける抗菌活性を測定した所、無添加と比較し何ら
活性の低下は認められなかつた。
実施例 5)
試験試料をエチルマルトール0.02%(1/5000
濃度)を使用する以外実施例−4と同じ培地
(pH7.0)、菌及び方法で実施した結果、培地の
pHの低下もなく、またグルカンの形成も見られ
なかった事により、完全に菌の生育を阻止するこ
とができた。[Table] From the results shown in Table 3, both maltol and ethylmaltol showed extremely remarkable effects in inhibiting bacterial growth. Example 4) 0.02% maltol in a heart infusion broth liquid medium (pH 7.0) supplemented with 2% sucrose
(1/5000 concentration), precultured, and cultured with Streptococcus mutans strain 3125001.
After adding 0.5% and culturing at 37℃ for 24 hours in a nitrogen desiccator, we checked the growth status of the bacteria. As a result, there was no decrease in the pH of the culture medium and no glucan formation was observed, so the bacteria were completely destroyed. was able to prevent the growth of. In addition, for the purpose of practical use of this sample, the antibacterial activity was measured in the presence of 0.5% sodium lauryl sulfate, and no decrease in activity was observed compared to when no additive was added. Example 5) The test sample was mixed with ethyl maltol 0.02% (1/5000
As a result of carrying out the experiment using the same medium (pH 7.0), bacteria, and method as in Example 4, except that the concentration of
Since there was no decrease in pH and no glucan formation was observed, bacterial growth was completely inhibited.
Claims (1)
有効成分として含有することを特徴とするう蝕菌
生育阻害剤。1. A caries growth inhibitor characterized by containing maltol and/or ethyl maltol as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22897384A JPS61109716A (en) | 1984-11-01 | 1984-11-01 | Agent for inhibiting growth of dental caries bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22897384A JPS61109716A (en) | 1984-11-01 | 1984-11-01 | Agent for inhibiting growth of dental caries bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61109716A JPS61109716A (en) | 1986-05-28 |
JPH0434968B2 true JPH0434968B2 (en) | 1992-06-09 |
Family
ID=16884770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22897384A Granted JPS61109716A (en) | 1984-11-01 | 1984-11-01 | Agent for inhibiting growth of dental caries bacteria |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61109716A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2342976A1 (en) * | 1998-09-23 | 2000-03-30 | Unilever Plc | Oral care compositions |
ES2911516T3 (en) | 2016-01-19 | 2022-05-19 | Achromaz Pte Ltd | A cosmetic composition and the use thereof for regulating skin quality |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5037260A (en) * | 1973-06-23 | 1975-04-07 | ||
JPS5141446A (en) * | 1974-08-09 | 1976-04-07 | Procter & Gamble | Shiko mushiba oyobi shisekiochensaserutameno osenkeikonogenshoshitakokoyososeibutsu |
JPS51139639A (en) * | 1975-04-01 | 1976-12-02 | Procter & Gamble | Tartar preventive composition |
JPS568679A (en) * | 1979-04-11 | 1981-01-29 | Fichera A T | Composition for controlling tobacco smoking and production thereof |
-
1984
- 1984-11-01 JP JP22897384A patent/JPS61109716A/en active Granted
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5037260A (en) * | 1973-06-23 | 1975-04-07 | ||
JPS5141446A (en) * | 1974-08-09 | 1976-04-07 | Procter & Gamble | Shiko mushiba oyobi shisekiochensaserutameno osenkeikonogenshoshitakokoyososeibutsu |
JPS51139639A (en) * | 1975-04-01 | 1976-12-02 | Procter & Gamble | Tartar preventive composition |
JPS568679A (en) * | 1979-04-11 | 1981-01-29 | Fichera A T | Composition for controlling tobacco smoking and production thereof |
Also Published As
Publication number | Publication date |
---|---|
JPS61109716A (en) | 1986-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5283173B2 (en) | Non-cariogenic materials and anti-cariogenic agents containing rare sugars | |
JPH0662408B2 (en) | Anti-caries and anti-periodontal composition | |
JP3614479B2 (en) | Periodontal disease-causing bacteria or caries-causing bacteria inhibitor, oral composition and food containing them | |
JP3241955B2 (en) | Oral composition | |
JPH0140005B2 (en) | ||
JPS61171423A (en) | Drug for alleviating dental caries and periodontosis | |
JPH0234322B2 (en) | ||
JPH1143442A (en) | Legionella bacteria resistant composition | |
JPH03240721A (en) | Composition for oral cavity | |
KR100450391B1 (en) | Toothpaste Composition | |
JP3481269B2 (en) | Antibacterial composition and antibacterial method | |
KR102438800B1 (en) | Composition comtaining lactic acid fermented noni extract as active ingredient for prevention or treatment of oral disease | |
JPH0434968B2 (en) | ||
KR20030089047A (en) | Composition for enhancing oral health | |
JPH0639375B2 (en) | Anti-caries agent | |
KR102269164B1 (en) | Composition for improvement of dental caries and periodontal disease using an extract of seeds of Phaseolus radiatus, etc. | |
JPS5835484B2 (en) | Oral composition | |
TW201117804A (en) | Sugar alcohol-containing antibacterial agent for inhibiting proliferation of periodontal disease-causing bacteria | |
KR102452255B1 (en) | Composition comprising deacetyl asperulosidic acid and/or asperulosidic acid as active ingredient for prevention or treatment of oral disease | |
JP2001321123A (en) | Anticariogenic food material and its composition | |
JP4796700B2 (en) | Antibacterial oral or external medicine composition | |
JPS6258324B2 (en) | ||
JP7362417B2 (en) | Growth inhibitors, oral compositions, and promoters of oral pathogenic bacteria | |
KR102055667B1 (en) | Toothpsate composites type gel tablet and that of manufacturing method | |
JPH0720854B2 (en) | Oral composition |